Shares of Mobia Medical, Inc. (NASDAQ:MOBI – Get Free Report) have earned an average rating of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $20.25.
Several research analysts recently weighed in on MOBI shares. JPMorgan Chase & Co. started coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They issued an “overweight” rating and a $15.00 target price for the company. BTIG Research assumed coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $19.00 price objective for the company. Bank of America assumed coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They set a “buy” rating and a $16.00 price objective on the stock. Wolfe Research initiated coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They set an “outperform” rating on the stock. Finally, Zacks Research upgraded Mobia Medical to a “hold” rating in a report on Wednesday, June 3rd.
Get Our Latest Analysis on MOBI
Insider Buying and Selling at Mobia Medical
Mobia Medical Stock Down 1.9%
MOBI opened at $10.85 on Wednesday. Mobia Medical has a 12 month low of $10.19 and a 12 month high of $15.29. The firm has a market cap of $360.75 million, a PE ratio of -0.56 and a beta of 2.84. The company has a 50 day simple moving average of $12.84.
Mobia Medical (NASDAQ:MOBI – Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The company reported ($19.30) earnings per share (EPS) for the quarter. The firm had revenue of $12.07 million for the quarter.
See Also
- Five stocks we like better than Mobia Medical
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.
